Filtered Listing Testing
Medical marijuana has been shown to lower eye pressure, a key factor in glaucoma. But is it safe to use?
BrightFocus Foundation, in partnership with three other global vision loss advocacy organizations, has declared Dec. 5 as World Geographic Atrophy Day.
In a new BrightFocus-funded study, researchers found an association between alterations in circadian rest-activity rhythms and risk of frailty incidence in older adults.
BrightFocus Foundation’s Alzheimer’s Fast Track, an immersive workshop for early-career scientists, was held Nov. 8-10 in Washington, D.C. and convened 80 talented Alzheimer’s researchers from 19 U.S. states and six countries, including Japan, Spain, and Sweden.
To achieve true health equity, we must ensure that all populations have equitable access to clinical trials and the benefits of medical research. With the right mix of resources, dedication, compassion, patience, and time, we can positively impact communities nationwide, write BrightFocus President and CEO Stacy Pagos Haller and board member Tonya M. Matthews, PhD, in a new op-ed.
In a first of its kind study, BrightFocus-funded researchers have identified a possible new way to improve drugs to treat glaucoma by studying a tiny part of the eye’s drainage system that plays a major role in eye pressure.
A potential drug rooted in initial grant funding from BrightFocus Foundation to Dr. Ilyas Washington gives hope to those suffering from Stargardt disease, a genetic form of macular degeneration.
BrightFocus Foundation’s 2023 annual report highlights an incredible year of pioneering neurodegenerative research.
Vision scientists from across the globe will convene at BrightFocus Foundation’s second Macular Fast Track program on October 23 in Torremolinos, Spain. The immersive workshop, which serves as the pre-symposium of the International Symposium on Retinal Degeneration (RD2023), trains promising graduate students, postdoctoral fellows, and other early-career scientists focused on vision research to help speed progress toward a cure for macular degeneration.
As we mark World Sight Day today, October 12, BrightFocus Foundation reaffirms its commitment to funding breakthrough research for macular degeneration and glaucoma and providing valuable resources for people living with low vision.
